This inventor holds 1 USPTO granted patent. Top assignee: The Brigham and Women's Hospital, Inc.. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Dhirendra Singh: Innovator in Lens Epithelial Cell Derived Growth Factor
Introduction
Dhirendra Singh is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of biomedical research, particularly in the area of growth factors related to lens epithelial cells. His work has implications for therapeutics and diagnostics, showcasing the potential of his inventions in medical applications.
Latest Patents
Dhirendra Singh holds a patent for a groundbreaking invention titled "Lens epithelial cell derived growth factor." This invention pertains to nucleic acids encoding a lens epithelial cell derived growth factor protein, including fragments and biologically functional variants thereof. The invention also encompasses therapeutics and diagnostics involving these proteins and genes, as well as agents that bind to them. He has 1 patent to his name.
Career Highlights
Dhirendra Singh is affiliated with Brigham and Women's Hospital, Inc., where he continues to advance his research and innovation in the medical field. His work is instrumental in exploring new avenues for treatment and diagnosis related to eye health.
Collaborations
Some of his notable coworkers include Toshimichi Shinohara and Leo T Chylack, Jr. Their collaborative efforts contribute to the ongoing research and development in the field of lens epithelial cell derived growth factors.
Conclusion
Dhirendra Singh's contributions to the field of biomedical research, particularly through his patent on lens epithelial cell derived growth factor, highlight his role as an innovator. His work at Brigham and Women's Hospital, Inc. and collaborations with esteemed colleagues further emphasize the impact of his research on medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
